Can green tea do that? A literature review of the clinical evidence (Q33451474)

26 July 2017

1 reference

title

Can green tea do that? A literature review of the clinical evidence (English)

1 reference

26 July 2017

0 references

0 references

Yuri Clement

1

1 reference

26 July 2017

language of work or name

English

0 references

publication date

22 May 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

49

1 reference

26 July 2017

issue

2-3

1 reference

26 July 2017

page(s)

83-87

1 reference

Oxidative stress in neurodegeneration: cause or consequence?

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green and black tea consumption and risk of stroke: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

A review of the epidemiological evidence on tea, flavonoids, and lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Consumption of green tea causes rapid increase in plasma antioxidant power in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Oxidative stress and vascular damage in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

What is oxidative stress?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Role of oxidative stress in cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea attenuates benzene-induced oxidative stress in pump workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea composition, consumption, and polyphenol chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

A prospective study of stomach cancer death in relation to green tea consumption in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

A nested case-control study of stomach cancer in relation to green tea consumption in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

A prospective study of green tea consumption and oral cancer incidence in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Cancer-preventive effects of drinking green tea among a Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Tea catechin consumption reduces circulating oxidized low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Protective effect of green tea against prostate cancer: A case‐control study in southeast China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Aging and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Case-control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

The multiethnic cohort study: exploring genes, lifestyle and cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Effects of green tea on weight maintenance after body-weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea consumption and prostate cancer risk in Japanese men: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Tea consumption and ovarian cancer risk in a population-based cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea consumption and lung cancer risk: the Ohsaki study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea consumption and the risk of pancreatic cancer in Japanese adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Cellular response to oxidative stress: signaling for suicide and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

A green tea extract high in catechins reduces body fat and cardiovascular risks in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea reverses endothelial dysfunction in healthy smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Oxidative damage and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Habitual green tea consumption and risk of an aneurysmal rupture subarachnoid hemorrhage: a case-control study in Nagoya, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Consumption of green tea favorably affects oxidative stress markers in weight-trained men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Antioxidant effects of tea: evidence from human clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea consumption and subsequent risk of gastric cancer by subsite: the JPHC Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Consumption of green and roasted teas and the risk of stroke incidence: results from the Tokamachi-Nakasato cohort study in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Effect of cocoa and tea intake on blood pressure: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Anti-obesity effects of green tea: from bedside to bench.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea and risk of breast cancer in Asian Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

The protective effect of habitual tea consumption on hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Prospective cohort study of green tea consumption and colorectal cancer risk in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Green tea consumption enhances survival of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Possible protective effect of green tea intake on risk of adult leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

Migration patterns and breast cancer risk in Asian-American women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.05.005

10.1016/J.YPMED.2009.05.005

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference